Sabra Healthcare REIT (NASDAQ:SBRA) Releases Earnings Results, Hits Expectations

Key Points

• Sabra reported Q results of $0.16 EPS (in line with estimates) and revenue of $221.75 million, a 20.9% year-over-year increase, and updated FY2026 guidance to EPS $1.55–$1.59.
• The REIT paid a quarterly dividend of $0.30 (annualized $1.20) for a yield of 5.9%, but its dividend payout ratio is high at 187.5%, which could raise sustainability concerns.
• Shares trade around $20.36 with a market cap of $5.13B and a P/E of 31.9; institutional ownership is very high at 99.4%, and analysts' consensus is a “Moderate Buy” with an average price target of $22.00.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) announced its earnings results on Wednesday. The real estate investment trust reported $0.16 earnings per share for the quarter, hitting analysts' consensus estimates of $0.16, Zacks reports. The firm had revenue of $221.75 million during the quarter, compared to analyst estimates of $204.53 million. Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The company's revenue for the quarter was up 20.9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.37 EPS. Sabra Healthcare REIT updated its FY 2026 guidance to 1.550-1.590 EPS.

Sabra Healthcare REIT Stock Performance

NASDAQ SBRA traded up $0.01 on Thursday, reaching $20.36. The stock had a trading volume of 164,494 shares, compared to its average volume of 2,553,148. Sabra Healthcare REIT has a 1-year low of $17.04 and a 1-year high of $21.07. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.29 and a quick ratio of 4.29. The company has a market cap of $5.13 billion, a P/E ratio of 31.88, a price-to-earnings-growth ratio of 1.62 and a beta of 0.67. The firm has a fifty day moving average of $20.22 and a two-hundred day moving average of $19.32.

Sabra Healthcare REIT Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, February 27th. Stockholders of record on Friday, February 13th were paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.9%. The ex-dividend date was Friday, February 13th. Sabra Healthcare REIT's dividend payout ratio (DPR) is currently 187.50%.

Institutional Trading of Sabra Healthcare REIT

A number of institutional investors have recently modified their holdings of the stock. Smartleaf Asset Management LLC lifted its holdings in shares of Sabra Healthcare REIT by 97.7% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust's stock worth $27,000 after acquiring an additional 714 shares during the period. Danske Bank A S acquired a new position in Sabra Healthcare REIT during the third quarter valued at approximately $30,000. Larson Financial Group LLC raised its position in Sabra Healthcare REIT by 42.3% during the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust's stock valued at $35,000 after purchasing an additional 553 shares in the last quarter. EverSource Wealth Advisors LLC lifted its stake in Sabra Healthcare REIT by 150.7% during the second quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust's stock worth $47,000 after purchasing an additional 1,536 shares during the last quarter. Finally, Quarry LP acquired a new stake in shares of Sabra Healthcare REIT in the 3rd quarter valued at $48,000. 99.40% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on SBRA shares. Wall Street Zen cut shares of Sabra Healthcare REIT from a "hold" rating to a "sell" rating in a research report on Friday, January 23rd. UBS Group lifted their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a "neutral" rating in a research report on Thursday, February 19th. Scotiabank increased their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a "sector perform" rating in a research report on Monday, March 2nd. Cantor Fitzgerald raised their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a "neutral" rating in a research note on Tuesday, February 17th. Finally, Citizens Jmp boosted their price target on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock a "market outperform" rating in a research report on Wednesday, February 18th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Sabra Healthcare REIT has an average rating of "Moderate Buy" and an average price target of $22.00.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc NASDAQ: SBRA is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra's tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.